home / stock / nktr / nktr quote
Last: | $1.83 |
---|---|
Change Percent: | -1.13% |
Open: | $1.79 |
Close: | $1.83 |
High: | $1.855 |
Low: | $1.76 |
Volume: | 1,346,924 |
Last Trade Date Time: | 05/15/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.83 | $1.79 | $1.83 | $1.855 | $1.76 | 1,346,924 | 05-15-2024 |
$1.77 | $1.72 | $1.77 | $1.79 | $1.66 | 1,453,673 | 05-14-2024 |
$1.75 | $1.86 | $1.75 | $1.928 | $1.685 | 3,032,911 | 05-13-2024 |
$1.76 | $1.65 | $1.76 | $1.87 | $1.63 | 2,360,209 | 05-10-2024 |
$1.6 | $1.64 | $1.6 | $1.69 | $1.6 | 970,000 | 05-09-2024 |
$1.64 | $1.64 | $1.64 | $1.725 | $1.52 | 2,036,205 | 05-08-2024 |
$1.5 | $1.64 | $1.5 | $1.67 | $1.48 | 1,754,897 | 05-07-2024 |
$1.65 | $1.6 | $1.65 | $1.67 | $1.55 | 911,605 | 05-06-2024 |
$1.57 | $1.74 | $1.57 | $1.74 | $1.55 | 1,140,601 | 05-03-2024 |
$1.67 | $1.71 | $1.67 | $1.79 | $1.59 | 2,476,533 | 05-02-2024 |
$1.65 | $1.45 | $1.65 | $1.65 | $1.445 | 1,713,678 | 05-01-2024 |
$1.46 | $1.45 | $1.46 | $1.52 | $1.4 | 814,438 | 04-30-2024 |
$1.46 | $1.35 | $1.46 | $1.53 | $1.35 | 1,607,134 | 04-29-2024 |
$1.32 | $1.33 | $1.32 | $1.38 | $1.31 | 559,095 | 04-26-2024 |
$1.32 | $1.36 | $1.32 | $1.37 | $1.29 | 1,054,027 | 04-25-2024 |
$1.38 | $1.37 | $1.38 | $1.42 | $1.37 | 958,000 | 04-24-2024 |
$1.42 | $1.39 | $1.42 | $1.43 | $1.31 | 1,099,928 | 04-23-2024 |
$1.36 | $1.31 | $1.36 | $1.41 | $1.29 | 1,970,248 | 04-22-2024 |
$1.24 | $1.33 | $1.24 | $1.33 | $1.2 | 4,717,823 | 04-19-2024 |
$1.32 | $1.32 | $1.32 | $1.36 | $1.27 | 3,575,770 | 04-18-2024 |
News, Short Squeeze, Breakout and More Instantly...
Nektar Therapeutics Reports First Quarter 2024 Financial Results PR Newswire SAN FRANCISCO , May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024 . Cash and ...
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO , May 2, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results fo...
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference PR Newswire SAN FRANCISCO ,...